International Stem Cell - Termination of coverage
Edison Investment Research is terminating coverage on Abacus Health Products (ABCS), ADL Bionatur (BNT), ASIT Biotech (ASIT), GAME Digital (GMD),...
91 Views
International Stem Cell - Biomedical sales more than double
International Stem Cell (ISCO) reported Q218 revenues of $3.0m, up 72.4% compared to Q217 mainly due to the biomedical business, which had...
44 Views
International Stem Cell - Moving forward in Parkinson's and TBI
International Stem Cell (ISCO) is an early-stage cell therapy company currently in clinical trials to treat Parkinson’s disease (PD). In November,...
66 Views
International Stem Cell - Interim Parkinson’s data
International Stem Cell recently announced interim six-month results from the first cohort of four patients in its Phase I trial of ISC-hpNSC in...
43 Views
Green light for second cohort
International Stem Cell recently announced that the data safety monitoring board (DSMB) for its Phase I trial of ISC-hpNSC in Parkinson’s disease...
73 Views
No more insights